A Study Evaluating the Efficacy and Safety of Mitapivat (AG-348) in Participants With Sickle Cell Disease (RISE UP)
Clinical trial NCT05031780 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05031780
- Sponsor
- Agios Pharmaceuticals, Inc.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-02-11
- Primary completion
- 2025-10-30
- Enrollment
- 286
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.